成人登革热伴血小板减少者血小板恢复不良的预测因素与临床结局
360例可分析患者中158例血小板恢复不良,年龄、白细胞计数和入组时病日均是其独立预测因素;恢复不良者住院更长,且接受预防性血小板输注者出血风险更高(OR 2.34,95%CI 1.18-4.63)。
要点
- 年龄较大、入组时病日较早、白细胞计数较低者更易出现血小板恢复不良。
- 血小板恢复不良者住院时间更长,但其他临床结局无显著差异。
- 血小板恢复不良者接受预防性输注反而与出血风险升高相关。
核心结论
- 登革热伴血小板减少患者中,年龄较大、就诊较早和白细胞计数较低与血小板恢复不良相关。
- 血小板恢复不良者接受预防性血小板输注不改善结局,反而可能增加出血风险。
- 血小板恢复不良的机制尚待明确。
研究设计与样本
- 多中心前瞻性研究的事后分析,数据来自成人登革热血小板研究(NCT01030211)。
主要发现
- 360例可分析患者中158例出现血小板恢复不良。
- 校正基线特征和血小板输注后,年龄、白细胞计数和入组时病日为血小板恢复不良的显著预测因素。
- 血小板恢复不良者住院时间更长,但无论是否输注,其他临床结局无显著差异。
- 血小板恢复与输注存在显著交互作用:恢复不良者接受预防性输注后出血风险更高(OR 2.34,95%CI 1.18-4.63)。
临床怎么用
- 对年龄较大、就诊较早、白细胞计数较低的登革热伴血小板减少患者应警惕血小板恢复不良。
- 血小板恢复不良者不建议以预防性血小板输注来改善结局。
局限性
- 本文为事后分析,证据强度受原始随机试验设计限制。
- 血小板恢复不良的机制尚未确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Platelet transfusion is common in dengue patients with thrombocytopenia. We previously showed in a randomized clinical trial that prophylactic platelet transfusion did not reduce clinical bleeding. In this study, we aimed to characterize the predictors and clinical outcomes of poor platelet recovery in transfused and nontransfused participants. METHODS: We analyzed patients from the Adult Dengue Platelet Study with laboratory-confirmed dengue with ≤20 000 platelets/μL and without persistent mild bleeding or any severe bleeding in a post hoc analysis. Poor platelet recovery was defined as a platelet count of ≤20 000/μL on Day 2. We recruited 372 participants from 5 acute care hospitals located in Singapore and Malaysia between 29 April 2010 and 9 December 2014. Of these, 188 were randomly assigned to the transfusion group and 184 to the control group. RESULTS: Of 360 patients, 158 had poor platelet recovery. Age, white cell count, and day of illness at study enrollment were significant predictors of poor platelet recovery after adjustment for baseline characteristics and platelet transfusion. Patients with poor platelet recovery had longer hospitalizations but no significant difference in other clinical outcomes, regardless of transfusion. We found a significant interaction between platelet recovery and transfusion; patients with poor platelet recovery were more likely to bleed if given a prophylactic platelet transfusion (odds ratio 2.34, 95% confidence interval 1.18-4.63). CONCLUSIONS: Dengue patients with thrombocytopenia who were older or presented earlier and with lower white cell counts were more likely to have poor platelet recovery. In patients with poor platelet recovery, platelet transfusion does not improve outcomes and may actually increase the risk of bleeding. The mechanisms of poor platelet recovery need to be determined. CLINICAL TRIALS REGISTRATION: NCT01030211.
引用
- Archuleta S, Chia PY, Wei Y, et al. Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study. Clin Infect Dis. 2020. PMID: 31626692. doi:10.1093/cid/ciz850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。